We are live on ! Find out more
DS

DRW Securities Portfolio holdings

AUM $7.21B
1-Year Est. Return 20.54%
This Fund
S&P 500
This Quarter Est. Return
-0.4%
1 Year Est. Return
+20.54%
3 Year Est. Return
+87.88%
5 Year Est. Return
+88.87%
10 Year Est. Return
+277.95%
AUM
$1.55B
AUM Growth
+$604M
Cap. Flow
+$652M
Cap. Flow %
41.94%
Top 10 Hldgs %
87.6%
Holding
537
New
83
Increased
41
Reduced
25
Closed
375

Top Buys

Rank Stock Value
1
SPY icon
State Street SPDR S&P 500 ETF Trust
SPY
+$903M
2
EEM icon
iShares MSCI Emerging Markets ETF
EEM
+$63.2M
3
EWY icon
iShares MSCI South Korea ETF
EWY
+$17.4M
4
FXI icon
iShares China Large-Cap ETF
FXI
+$15.1M
5
DIA icon
State Street SPDR Dow Jones Industrial Average ETF Trust
DIA
+$12M

Top Sells

Rank Stock Value
1
VCSH icon
Vanguard Short-Term Corporate Bond ETF
VCSH
+$14.4M
2
AAPL icon
Apple
AAPL
+$12.2M
3
IVV icon
iShares Core S&P 500 ETF
IVV
+$9.35M
4
MSFT icon
Microsoft
MSFT
+$9.25M
5
CME icon
CME Group
CME
+$7.13M

Sector Composition

Rank Sector Weight
1 Healthcare 0.51%
2 Consumer Discretionary 0.26%
3 Technology 0.22%
4 Communication Services 0.19%
5 Financials 0.18%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
SYBX
126
DELISTED
Synlogic
SYBX
$178K 0.01%
+1,267
New +$196K
PBR icon
127
CALL
Petrobras
PBR
$121B
$177K 0.01%
+12,500
New +$164K
OMED
128
DELISTED
OncoMed Pharmaceuticals, Inc.
OMED
$171K 0.01%
53,740
+40,000
+291% +$110K
SRRA
129
DELISTED
Sierra Oncology, Inc. Common Stock
SRRA
$166K 0.01%
2,000
+1,000
+100% +$113K
ARRY
130
DELISTED
Array Biopharma Inc
ARRY
$163K 0.01%
10,000
-5,000
-33% -$80.1K
AUPH icon
131
Aurinia Pharmaceuticals
AUPH
$1.97B
$162K 0.01%
+31,300
New +$167K
CLSD
132
DELISTED
Clearside Biomedical
CLSD
$161K 0.01%
+1,000
New +$122K
EIGR
133
DELISTED
Eiger BioPharmaceuticals, Inc.
EIGR
$158K 0.01%
+533
New +$157K
XENE icon
134
Xenon Pharmaceuticals
XENE
$6.32B
$147K 0.01%
30,000
– –
BLPH
135
DELISTED
Bellerophon Therapeutics, Inc.
BLPH
$146K 0.01%
+4,667
New +$148K
ADVM
136
DELISTED
Adverum Biotechnologies
ADVM
$145K 0.01%
2,500
-500
-17% -$31.1K
KALV
137
DELISTED
KalVista Pharmaceuticals
KALV
$142K 0.01%
15,000
+3,000
+25% +$31.4K
TARA icon
138
Protara Therapeutics
TARA
$226M
$134K 0.01%
1,342
+375
+39% +$34.1K
ONCS
139
DELISTED
OncoSec Medical Incorporated
ONCS
$132K 0.01%
+318
New +$130K
SYRE icon
140
Spyre Therapeutics
SYRE
$8.87B
$128K 0.01%
515
– –
RNAC icon
141
Cartesian Therapeutics
RNAC
$232M
$122K 0.01%
+400
New +$114K
IMDZ
142
DELISTED
Immune Design Corp.
IMDZ
$122K 0.01%
37,000
+20,000
+118% +$70.8K
AES icon
143
CALL
AES
AES
$10.6B
$119K 0.01%
+10,500
New +$114K
OVID icon
144
Ovid Therapeutics
OVID
$435M
$108K 0.01%
+15,317
New +$124K
NBRV
145
DELISTED
Nabriva Therapeutics plc Ordinary Shares Ireland
NBRV
$106K 0.01%
+84
New +$124K
CYTK icon
146
Cytokinetics
CYTK
$11B
$101K 0.01%
+14,000
New +$120K
RGLS
147
DELISTED
Regulus Therapeutics
RGLS
$97K 0.01%
1,125
+292
+35% +$39.1K
ALDX icon
148
Aldeyra Therapeutics
ALDX
$91.7M
$90K 0.01%
12,000
– –
CHMA
149
DELISTED
Chiasma, Inc. Common Stock
CHMA
$86K 0.01%
+57,000
New +$90.4K
GERN icon
150
Geron
GERN
$911M
$85K 0.01%
20,000
+10,000
+100% +$27K
4 5
6
7 8

Similar funds

CFG
Citizens Financial Group Providence, Rhode Island $7.19B AUM 23.93% 1-Year Est. Return
FPP
Findlay Park Partners London, United Kingdom $7.17B AUM 17.27% 1-Year Est. Return
UB
UMB Bank Kansas City, Missouri $7.16B AUM 20.88% 1-Year Est. Return
TSC
Two Seas Capital Rye, New York $7.15B AUM 169.27% 1-Year Est. Return
FPA
First Pacific Advisors El Segundo, California $7.14B AUM 21.51% 1-Year Est. Return
SC
Saturna Capital Bellingham, Washington $7.13B AUM 35.47% 1-Year Est. Return
GLF
Groupe la Francaise Paris, France $7.29B AUM 37.28% 1-Year Est. Return
SIMG
Stephens Investment Management Group Houston, Texas $7.3B AUM 41.96% 1-Year Est. Return

DRW Securities's Q1 2018 Portfolio in Review

As of Q1 2018, DRW Securities held 537 positions worth $1.55B, up 64% from $951M the previous quarter. Its ten largest holdings account for 88% of the portfolio.

DRW Securities deployed $652M of net new capital in Q1 2018, opening 83 new positions and adding to 41 existing holdings. Its largest new stake was iShares MSCI South Korea ETF: 231,412 shares worth $17.5M.

By sector, the portfolio is most concentrated in Healthcare at 0.51% of assets, down from 4.9% a quarter earlier, followed by Consumer Discretionary and Technology.

On the sell side, the largest reduction was Vanguard S&P 500 ETF, an estimated $5.93M trimmed.

  • DRW Securities's largest Q1 2018 buy was iShares MSCI South Korea ETF: 231,412 shares worth $17.5M.
  • DRW Securities added most to State Street SPDR S&P 500 ETF Trust in Q1 2018, an estimated $903M increase.
  • DRW Securities's biggest Q1 2018 reduction was Vanguard S&P 500 ETF, cutting an estimated $5.93M.
  • DRW Securities fully exited Vanguard Short-Term Corporate Bond ETF in Q1 2018, selling an estimated $14.4M.
  • DRW Securities's ten largest holdings make up 88% of its $1.55B portfolio in Q1 2018.
  • DRW Securities opened 83 new positions and closed 375 in Q1 2018.
  • DRW Securities's portfolio value rose 64% quarter-over-quarter to $1.55B.

Based on DRW Securities's 13F filing for Q1 2018, filed 14 May 2018.